Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
group | 0.400 | None | 0.949 | 155 | 0 | 1996 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
phenotype | 0.100 | None | 1.000 | 53 | 0 | 1996 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
group | 0.400 | None | 0.981 | 53 | 0 | 1998 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
phenotype | 0.100 | None | 1.000 | 50 | 0 | 2005 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
phenotype | 0.100 | None | 0.957 | 47 | 0 | 1995 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
group | 0.500 | None | 0.978 | 46 | 0 | 1996 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
group | 0.100 | None | 0.970 | 33 | 0 | 1998 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 31 | 0 | 1996 | 2017 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 22 | 0 | 1997 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 2012 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 0.952 | 20 | 0 | 1997 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 1995 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 19 | 0 | 2009 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 1996 | 2017 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2007 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2007 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
group | 0.100 | None | 0.933 | 15 | 0 | 1996 | 2015 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2007 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 2003 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2003 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
group | 0.400 | None | 1.000 | 14 | 0 | 1997 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 1996 | 2007 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2008 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
phenotype | 0.100 | None | 0.917 | 12 | 0 | 1999 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2004 | 2019 |